Parisi Gray Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Parisi Gray Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-80	Closed	-$11K	–	568
2021 Q2	$11K	Buy	+80	New	+$10.5K	﹤0.01%	439
2019 Q2	–	Sell	-80	Closed	-$7K	–	468
2019 Q1	$7K	Hold	80	–	–	﹤0.01%	420
2018 Q4	$6K	Hold	80	–	–	﹤0.01%	458
2018 Q3	$8K	Hold	80	–	–	﹤0.01%	435
2018 Q2	$8K	Hold	80	–	–	0.01%	446
2018 Q1	$7K	Hold	80	–	–	0.01%	474
2017 Q4	$7K	Buy	+80	New	+$6.7K	0.01%	505

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Parisi Gray Wealth Management's XBI Position: Q3 2021 in Review

Parisi Gray Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2021, closing a stake of 80 shares — an estimated $11K sold.

Parisi Gray Wealth Management first reported a position in XBI in Q4 2017 and held it in 7 quarters. The position peaked at $11K in Q2 2021. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

Parisi Gray Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2021 after selling out during the quarter.
Parisi Gray Wealth Management sold 80 State Street SPDR S&P Biotech ETF shares in Q3 2021, an estimated $11K.
Parisi Gray Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 7 quarters.
Parisi Gray Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $11K in Q2 2021.
635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on Parisi Gray Wealth Management's 13F filing for Q3 2021, filed 16 Nov 2021.